EFFICACY AND SAFETY OF TOFACITINIB AFTER FAILURE OF ANTI-TNF AGENT IN PATIENTS WITH ULCERATIVE COLITIS: A US-BASED PROPENSITY MATCHED COHORT STUDY

被引：0
作者：
Kochhar, Gursimran S.
Desai, Aakash
Dulai, Parambir S.
Cross, Raymond K.
Farraye, Francis A.
Regueiro, Miguel D.
El-Hachem, Sandra
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1711
引用
收藏
页码：S646 / S647
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of ustekinumab in psoriatic arthritis after anti-TNFα failure in routine practice
    Michela, Matthias
    Reguiai, Ziad
    Fauconier, Marion
    Brochot, Pascal
    Eschard, Jean-Paul
    Salmon, Jean-Hugues
    THERAPIE, 2016, 71 (03): : 281 - 286
  • [42] The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
    Allez, M.
    Vermeire, S.
    Mozziconacci, N.
    Michetti, P.
    Laharie, D.
    Louis, E.
    Bigard, M. -A.
    Hebuterne, X.
    Treton, X.
    Kohn, A.
    Marteau, P.
    Cortot, A.
    Nichita, C.
    van Assche, G.
    Rutgeerts, P.
    Lemann, M.
    Colombel, J. -F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 31 (01) : 92 - 101
  • [43] Effect of mirikizumab on clinical and endoscopic outcomes after 1 anti-TNF failure in patients with moderately to severely active Ulcerative Colitis
    Hart, A.
    Martin-Arranz, M. D.
    Laharie, D.
    Matsuoka, K.
    Dhesi, E.
    Redondo, I.
    Baygani, S.
    Zaremba-Pechmann, L.
    Samaan, K.
    Navabi, S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I27 - I28
  • [44] Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus Tofacitinib
    Kappelman, Michael D.
    Long, Millie D.
    Zhang, Xian
    Lin, Feng-Chang
    Weisbein, Laura
    Chen, Wenli
    Burris, Jessica
    Dorand, Jennifer E.
    Parlett, Lauren E.
    Fehlmann, Tara
    Brensinger, Colleen M.
    Haynes, Kevin
    Nair, Vinit
    Kaul, Alan F.
    Dobes, Angela
    Lewis, James D.
    CROHNS & COLITIS 360, 2023, 5 (03)
  • [45] EFFECT OF MIRIKIZUMAB ON CLINICAL AND ENDOSCOPIC OUTCOMES AFTER 1 ANTI-TNF FAILURE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Hart, Ailsa
    Martin-Arranz, Maria Dolores
    Laharie, David
    Matsuoka, Katsuyoshi
    Dhesi, Endip
    Redondo, Isabel
    Baygani, Simin
    Zaremba-Pechmann, Liliana
    Samaan, Karen H.
    Navabi, Seyedehsan
    GASTROENTEROLOGY, 2024, 166 (05) : S828 - S828
  • [46] Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study
    Gabrielli, Anna Maria Carvalhas
    Ferretti, Francesca
    Monico, Camilla Maria
    Tombetti, Enrico
    Maconi, Giovanni
    Romeo, Samanta
    Sed, Nicole Piazza O.
    Caprioli, Flavio
    Mazzola, Anna Maria
    Alicante, Saverio
    Berte, Roberto
    Lolli, Elisabetta
    Scribano, Maria Lia
    Buscarini, Elisabetta
    Ricci, Chiara
    Carmagnola, Stefania
    Ardizzone, Sandro
    Cannatelli, Rosanna
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (05) : 1785 - 1792
  • [47] Gari-leo prospective study on anti-TNF therapy in ulcerative colitis relapse patients
    Kato, S.
    Kani, K.
    Ishibashi, A.
    Oka, M.
    Nagoshi, S.
    Yakabi, K.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S298 - S298
  • [48] REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY
    Barberio, B.
    Zingone, F.
    Marinelli, C.
    Maccarone, M. C.
    Ghisa, M.
    Massimi, D.
    Gubbiotti, A.
    D'Inca, R.
    Savarino, E. V.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S118 - S118
  • [49] Editorial: real-world evidence of tofacitinib and vedolizumab in ulcerative colitis-are we one step closer to better positioning therapies after anti-TNF failure?
    Ernest-Suarez, Kenneth
    Lu, Cathy
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (06) : 733 - 734
  • [50] Association of a Panel of Anti-Microbial Antibodies With Disease Behavior and Response to Anti-TNF Therapy in a Cohort of Patients With Ulcerative Colitis
    Kevans, David
    Waterman, Matti
    Xu, Wei
    Stempak, Joanne M.
    Zhang, Lucy
    Nguyen, Geoffrey C.
    Croitoru, Ken
    Greenberg, Gordon R.
    Steinhart, A. Hillary
    Van Assche, Gert A.
    Silverberg, Mark S.
    GASTROENTEROLOGY, 2013, 144 (05) : S637 - S637
12345